NutraNomics, Inc. (NNRX) Meeting Demand of Growing Gluten-Free Market

NutraNomics has engaged in the research and development of nutritional food products since its founding in 1995. Two years after it was started, the company produced and branded its own product line and began selling these products to retail and wholesale outlets. It has also produced formulas for hundreds of other companies.

At present, NutraNomics is a leading brand for the manufacture of safe, high-quality vitamins and supplements. What sets NutraNomics’ products apart from approximately 95 percent of multi-vitamins available for purchase today is their composition. Nearly all multi-vitamins are isolated and/or synthetic, which makes them unnatural or lacking in critical nutritional components. Since they are “foreign” to the human body, their nutritional value and efficacy are greatly hampered.

NutraNomics’ health supplements, however, are superior food-based and plant-based food products filled with nutritional components that rejuvenate the body and give it greater energy and vitality. The products are specifically crafted to meet strict dietary needs, as they have no genetically modified organisms or wheat gluten. All of these products are based on the company’s proprietary Assimilation Enhancing System® (AES), a patented enzyme blend that increases nutrient bioavailability and aids in digestion.

Because they are gluten-free, NutraNomics’ health products have appeal among healthy living-driven consumers. Consumer interest in a gluten-free lifestyle has been growing in recent years. In 2008, sales of gluten-free products topped $1.75 billion, according to Nielsen. The New York Times notes that in 2013, gluten-free product sales shot up to $10.5 billion. By 2016, the gluten-free industry is projected to be worth $15 billion in annual sales.

In 2012, a study showed that around 2.1 million adults in the United States have celiac disease (0.9% of the total U.S. population). The study also projected that as many as another 1.8 million Americans have celiac disease but are undiagnosed. However, much of the growth in the gluten-free market has not been driven by consumers with celiac disease or gluten intolerance, but by consumers who are flocking toward healthy living. Nielsen reports that 11 percent of American households purchased gluten-free in 2013, up from 5 percent in 2010.

NutraNomics reported in late March that it would be expanding the market availability of its health products in the United States. Currently, NutraNomics has a developed global sales presence, with sales personnel in United States, Canada, Japan, Singapore, the Philippines, Malaysia, Korea, and Poland. The products can be purchased through the company’s web-based e-commerce engine as well.

According to the Nutritional Business Journal, sales of nutritional supplements topped $32 billion in 2012 and are expected to reach $60 billion in 2021. As demand for health products strengthens, NutraNomics looks to leverage key business relationships and emerge as a stronger leader in raising consumer awareness of healthy living and eating.

For more information, visit: www.nutranomics.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net